MIR6839

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, MIR6839 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MIR6839’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where MIR6839 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR6839 is over-expressed in tumor.

BRCA and LUAD are the cancer types where MIR6839 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR6839 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
BRCAFemaleAll+0.083.0296view →
LUADAllAll+0.076.0431view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

MIR6839–BRCA

Tumor-vs-normal expression box plot for MIR6839 RNA in BRCA.

Open the BRCA breakdown →

Exploration